TPG enters its August 6 earnings report having gained 19% in a month — yet the options market tells a more nuanced story beneath the rally.
The sharpest signal is how dramatically put/call positioning has unwound. The PCR now reads 1.42, nearly 1.4 standard deviations below the 20-day mean of 3.03 — meaning the market has rotated hard from historically bearish options positioning into something far more balanced. The 52-week PCR range runs from 0.32 to 6.63, and for most of the past two months it was anchored near the high end of that range. The recent collapse in put demand, coinciding almost exactly with TPG's price rebound from the mid-$30s to $48.98, suggests a meaningful short-covering and sentiment reset rather than fresh bullish conviction. The borrow market corroborates the lack of urgency: availability is generous at roughly 10x the current short interest, and borrowing costs have fallen 16% week-on-week to just 0.40% annualised — conditions that make it easy to short but give no reason to rush.
Short interest itself occupies an interesting middle ground. At 8.4% of the free float — with 7.3 days to cover — shorts are not trivial. But the position has barely moved: down less than 0.6% on the week, up 2.4% on the month. The slow drift higher in recent months, followed by a gentle pullback this week, looks more like holders sitting on existing positions than a fresh directional bet. With availability so ample, there is no mechanical squeeze pressure regardless of how the print lands.
Analysts are reluctant bulls at best. Morgan Stanley's Michael Cyprys cut his target from $60 to $54 on July 21 while staying at Equal-Weight — a bellwether signal of reduced conviction from a cautious sideline position. The broader analyst trend over the past few months has been target reductions across the board, even from firms maintaining positive ratings, with Goldman Sachs previously slashing from $80 to $55 in April. The consensus mean target of $56 implies roughly 14% further upside from current levels, but the stock has already closed most of that gap in a month. The bull case centres on TPG's forward EPS trajectory, which factor scores rank in the 86th percentile on 12-month forward growth — an unusually strong reading for the sector. The bear case is simpler: quality metrics have been eroding relative to peers such as KKR and ARES, and the stock's EPS surprise rank sits in just the 8th percentile, meaning the company has a recent history of missing estimates. That combination — strong forward expectations, weak recent delivery — creates a binary setup.
Among institutional holders, Darlington Partners built a 9 million-share position in Q1, adding over 4 million shares, and Millennium put on 2.2 million new shares — both signals that sophisticated money was buying the dip aggressively. The peer group has moved with TPG: HLNE gained 13.5% on the week and OWL 17.9%, suggesting sector-wide re-rating rather than a TPG-specific catalyst. The earnings print will therefore test whether TPG's fundamental delivery can catch up to a stock price that has already moved decisively — and whether the EPS surprise record is about to change direction.
See the live data behind this article on ORTEX.
Open TPG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
